4/1/2026Salubris Unveils Long-Acting Blood Pressure siRNA Data at ACC 2026

4/1/2026Alphamab and CSPC Win Phase III Breast Cancer Success for KN026 Neo-He...

4/1/2026Fosun Pharma Wins China Trial Nod for Teva-Partnered FXB0871

4/1/2026Abbisko Wins EMA Orphan Drug Designation for Irpagratinib in Liver Can...

3/31/2026Huahui Launches World's First Approved Hepatitis D Antibody Drug in Ch...

3/31/2026Connect Biopharma Reports Promising Late-Stage China Results for Eczem...

3/31/2026Braveheart Bio Posts Promising Mid-Stage China Data for HCM Drug Licen...

3/31/2026Innovent Publishes Strong Phase II Mazdutide 9 mg Obesity Data as Chin...

3/31/2026Simcere Highlights Late-Breaking Phase III Success for Rademikibart in...

3/30/2026Dizal Reports Strong First-Line ELCC 2026 Data for ZEGFROVY in Uncommo...

3/30/2026Enhertu Wins First Global Approval in Neoadjuvant HER2-Positive Early ...

3/30/2026China Approves Claruvis's Retoxin, Marking New Milestone in Recombinan...

3/30/2026Almirall Partners Shanghai Huaota in $340 Million Dermatology Antibody...

3/30/2026AZ/Amgen's Tezspire Wins China Approval for Asthma and CRSwNP

3/30/2026Abbisko Wins FDA Orphan Drug Designation for ABSK061 in Achondroplasia

3/27/2026CStone Reports Promising Clinical Progress for Trispecific Antibody CS...

3/26/2026Kelun-Biotech Secures IND Approval for SKB-103 in Advanced Solid Tumor...

3/26/2026CSPC Reports Promising Phase 1 Data for B7-H3 ADC SYS6043 in Nasophary...

3/26/2026Novo Nordisk 'Triple-G' Diabetes Candidate Advances to Phase 3 in Chin...

3/25/2026Innovent Eyes China Approval as IBI302 Matches Eylea in Phase 3 nAMD S...

3/25/2026BrightGene Reports Positive Phase 1 Data for Oral GLP-1/GIP Weight-Los...

3/25/2026Insilico Launches PandaClaw to Streamline AI-Driven Drug Discovery

3/25/2026Innovent Reports Positive Phase 3 STAR Results for IBI302 in nAMD

3/25/2026Hope Medicine Advances HMI-115 Into Phase III for Endometriosis

3/24/2026LG Chem's Tigulixostat Advances to Phase 3 in China Through Innovent P...

3/24/2026Sanofi Opens Chengdu Innovation Hub to Strengthen China Operations

3/24/2026RemeGen's Disitamab Vedotin Approved in China for HER2-Low Breast Canc...

3/23/2026Dizal Reports Positive Phase III WU-KONG28 Results for Sunvozertinib i...

3/23/2026CTTQ Reports Updated Phase I Data for EGFR/c-MET Bispecific TQB2922 in...

3/23/2026Hengrui Expands HER3 ADC SHR-A2009 Data Across Mono and Combination Se...

Page:1/22 Total number of articles:656: [First][<<] [1] [2] [3] [4] [5] [>>] [End]